Massachusetts Financial Services’s Integra LifeSciences IART Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q2
Sell
-300,488
Closed -$16.7M 857
2019
Q1
$16.7M Buy
300,488
+22,333
+8% +$1.14M 0.01% 553
2018
Q4
$12.5M Buy
278,155
+120,891
+77% +$6.63M 0.01% 566
2018
Q3
$10.4M Buy
157,264
+10,705
+7% +$665K ﹤0.01% 620
2018
Q2
$9.44M Sell
146,559
-21,644
-13% -$1.34M ﹤0.01% 633
2018
Q1
$9.31M Sell
168,203
-226,785
-57% -$11.9M ﹤0.01% 624
2017
Q4
$18.9M Sell
394,988
-56,321
-12% -$2.76M 0.01% 515
2017
Q3
$22.8M Buy
451,309
+22,262
+5% +$1.14M 0.01% 489
2017
Q2
$23.4M Sell
429,047
-32,863
-7% -$1.57M 0.01% 494
2017
Q1
$19.5M Sell
461,910
-379,308
-45% -$16.2M 0.01% 507
2016
Q4
$36.1M Buy
841,218
+95,726
+13% +$3.89M 0.02% 414
2016
Q3
$30.8M Buy
745,492
+82,970
+13% +$3.48M 0.02% 446
2016
Q2
$26.4M Buy
+662,522
New +$23.8M 0.01% 457

Other funds holding IART

Massachusetts Financial Services's IART Position: Q2 2019 in Review

Massachusetts Financial Services sold out of Integra LifeSciences (IART) in Q2 2019, closing a stake of 300,488 shares — an estimated $16.7M sold.

Massachusetts Financial Services first reported a position in IART in Q2 2016 and held it in 12 quarters. The position peaked at $36.1M in Q4 2016. 262 funds tracked by Wall St. Rank hold IART as of Q2 2019.

  • Massachusetts Financial Services reported no remaining Integra LifeSciences position as of Q2 2019 after selling out during the quarter.
  • Massachusetts Financial Services sold 300,488 Integra LifeSciences shares in Q2 2019, an estimated $16.7M.
  • Massachusetts Financial Services first reported a position in Integra LifeSciences in Q2 2016 and held it in 12 quarters.
  • Massachusetts Financial Services's Integra LifeSciences position peaked at $36.1M in Q4 2016.
  • 262 funds tracked by Wall St. Rank held Integra LifeSciences as of Q2 2019.

Based on Massachusetts Financial Services's 13F filing for Q2 2019, filed 14 Aug 2019.